Latest filing published 27 Nov 2023 for Dexcom Inc, €237k.
Filing timeline
BuySaleInsider track record
Girish Naganathan: trading record in brief
Girish Naganathan discloses dealings in Dexcom Inc to SEC (Form 4). The record holds 3 filings, for trades running from 8 November 2022 to 9 November 2023.
Sales make up the whole of the open-market record (1 sale, €237k). Outside the open market, there are 2 share grants. In 2023 alone, the filings show no purchases and 1 sale.
Most recently, on 27 November 2023, the filings show an open-market sale worth €237k in Dexcom Inc. The median gap between a trade and its publication by SEC (Form 4) is 6 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Girish Naganathan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,725 shares@ US$93.27100.0% of flowCommon StockSEC:0001093557-23-000236:0
- 18,776 shares@ US$0.0010.0% of flowCommon StockSEC:0001093557-23-000053:0
- 31,449 shares@ US$0.0010.0% of flowCommon StockSEC:0001093557-22-000173:0
3 of 3 declarations
